207 related articles for article (PubMed ID: 30693340)
1. Current progress in searching for clinically useful biomarkers of blood-brain barrier damage following cerebral ischemia.
Li W; Pan R; Qi Z; Liu KJ
Brain Circ; 2018; 4(4):145-152. PubMed ID: 30693340
[TBL] [Abstract][Full Text] [Related]
2. Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis?
Jin X; Liu J; Liu W
Curr Neurovasc Res; 2014; 11(3):254-62. PubMed ID: 24875486
[TBL] [Abstract][Full Text] [Related]
3. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
4. Blood Occludin Level as a Potential Biomarker for Early Blood Brain Barrier Damage Following Ischemic Stroke.
Pan R; Yu K; Weatherwax T; Zheng H; Liu W; Liu KJ
Sci Rep; 2017 Jan; 7():40331. PubMed ID: 28079139
[TBL] [Abstract][Full Text] [Related]
5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
6. Normobaric Hyperoxia Reduces Blood Occludin Fragments in Rats and Patients With Acute Ischemic Stroke.
Shi S; Qi Z; Ma Q; Pan R; Timmins GS; Zhao Y; Shi W; Zhang Y; Ji X; Liu KJ
Stroke; 2017 Oct; 48(10):2848-2854. PubMed ID: 28931617
[TBL] [Abstract][Full Text] [Related]
7. tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
Kim JS
J Stroke; 2019 May; 21(2):160-174. PubMed ID: 31161761
[TBL] [Abstract][Full Text] [Related]
8. Oxygen or cooling, to make a decision after acute ischemia stroke.
Liu WC; Jin XC
Med Gas Res; 2016; 6(4):206-211. PubMed ID: 28217292
[TBL] [Abstract][Full Text] [Related]
9. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
10. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
12. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Muhammad S; Planz O; Schwaninger M
Cerebrovasc Dis Extra; 2016; 6(2):50-9. PubMed ID: 27560521
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier integrity of stroke patients presenting in an extended time window.
Butler J; Heidari P; Blayney S; Hitomi E; Luby M; Leigh R
BMC Neurol; 2020 Feb; 20(1):54. PubMed ID: 32054451
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis in acute stroke patients with cerebral small vessel disease.
Pantoni L; Fierini F; Poggesi A
Cerebrovasc Dis; 2014; 37(1):5-13. PubMed ID: 24355873
[TBL] [Abstract][Full Text] [Related]
15. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
[TBL] [Abstract][Full Text] [Related]
16. Angioedema and Hemorrhage After 4.5-Hour tPA (Tissue-Type Plasminogen Activator) Thrombolysis Ameliorated by T541 via Restoring Brain Microvascular Integrity.
Chen QF; Liu YY; Pan CS; Fan JY; Yan L; Hu BH; Chang X; Li Q; Han JY
Stroke; 2018 Sep; 49(9):2211-2219. PubMed ID: 30354988
[TBL] [Abstract][Full Text] [Related]
17. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
[TBL] [Abstract][Full Text] [Related]
18. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
19. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
